GeoVax Labs, Inc. Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial
Links shared publicly online about this topic.
- 689total visits
GeoVax Labs, Inc. Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the Company), an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it
View full resource at medicalnewstoday.com
Tags: Vaccination, HIV, AIDS, STD, Vaccine
Most Recently Shared on November 30, 2010 at 6:05 pm By:
GeoVax Labs, Inc. Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial http://mnt.to/3Nhk
Also Shared By:
GeoVax Labs, Inc. Strategy Supported by Encouraging Results of European Therapeutic HIV/AIDS Vaccine Trial - Drugs.com MedNews
drugs.com — “Success In Viral Load Reduction Control of Virus, By Vaccine Recipient s Immune System Who Have Been Weaned from ART Therapy Encouraging News for HIV AIDS Vacci” View full resource at drugs.com
Most Recently Shared on November 29, 2010 at 3:16 pm By:
Drugs and Devices OW OW Health
GeoVax Labs, Inc. Strategy Supported by Encouraging Results of European Therapeutic HIV/AIDS Vaccine Trial... http://bit.ly/ehHsRn #drug
Advertisement
MNT HIV/Aids
@mnt_hivaids
GeoVax Labs, Inc. Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial http://mnt.to/3Nhk #hivaids
1 year ago...